Login
|
New Account
AAAAAA
ITA
ENG
Results:
1-3
|
Results: 3
A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma
Authors:
Sanz-Altamira, PM O'Reilly, E Stuart, KE Raeburn, L Steger, C Kemeny, NE Saltz, LB
Citation:
Pm. Sanz-altamira et al., A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma, ANN ONCOL, 12(4), 2001, pp. 501-504
A Phase II study of irinotecan in patients with advanced hepatocellular carcinoma
Authors:
O'Reilly, EM Stuart, KE Sanz-Altamira, PM Schwartz, GK Steger, CM Raeburn, L Kemeny, NE Kelsen, DP Saltz, LB
Citation:
Em. O'Reilly et al., A Phase II study of irinotecan in patients with advanced hepatocellular carcinoma, CANC CYTOP, 91(1), 2001, pp. 101-105
A Phase II study of irinotecan in patients with advanced hepatocellular carcinoma
Authors:
O'Reilly, EM Stuart, KE Sanz-Altamira, PM Schwartz, GK Steger, CM Raeburn, L Kemeny, NE Kelsen, DP Saltz, LB
Citation:
Em. O'Reilly et al., A Phase II study of irinotecan in patients with advanced hepatocellular carcinoma, CANCER, 91(1), 2001, pp. 101-105
Risultati:
1-3
|